Image For Activity Cover
Early Career Genetic Professionals Workshop - Building Leadership/Management Skills

Presentations followed by learner/presenter engagement

First time Users

First time users: You will need to check your degree as you created an ACMG account. The system designates educational credits according to your degree. Be sure you are logged in (do you see your name on the top right under the ACMG Genetics Academy logo?). If not, login before proceeding.

How to access the Academy for the first time

About this course

Early Career Genetic Professionals Workshop - Building Leadership/Management Skills

Presentations followed by learner/presenter engagement

Thursday, May 14, 2020

1:00 pm – 2:30 pm ET

www.acmgeducation.net

 

Genetics trainees must complete fellowship programs to acquire the specialized knowledge and sufficient hands-on experience to perform as accredited professionals. While the fellowships are rigorous in teaching genetics, other professional skill sets crucial for a successful career may receive less emphasis. This 90-minute session is aimed to provide trainees and early career faculty members with information and resources relevant to 1) business aspects of running a laboratory or clinical practice, and 2) personnel management. Three experienced leaders in genetics will provide insights from their early career development and share critical tips and resources.

During the first 45 minutes of the session, the speakers will each describe their experience on one of the following topics for 15 minutes each. The speakers are encouraged to give specific examples and provide “takeaway” lessons from their experience. Audience and moderator questions will then be discussed by the panel speakers.

Three areas speakers will address:

  1. Personnel Management - What qualities to look for during interview/hiring to build functional teams?  How to resolve interpersonal conflicts and manage challenging employees How to change jobs while maintaining good relationships with former employers and colleagues.
  2. Finance and Budgeting - Learn the important aspects of a laboratory budget and billing and reimbursement of tests.
  3. Business and Marketing - For laboratory geneticists, how to select which test to develop (clinical utility, target market, establishing ability to be competitive, etc.) and market the test effectively. For clinical geneticists, how to decide among labs for individual tests and address market forces

Target Audience

Graduate, genetic counseling and medical students and trainees.

Agenda

Elaine Lyon, PhD FACMG             Personnel Management

Soma Das, PhD FACMG               Finance and Budgeting

Peter Hulick, MD FACMG            Business and Marketing

Discussion and Q&A                     

 

Learning Objectives

At the conclusion of this session, participants should be able to:

  1. Develop strategies regarding what qualities to look for during interview/hiring to build functional teams
  2. Develop strategies on how to resolve interpersonal conflicts and manage challenging employees
  3. Develop strategies on how to change jobs while maintaining good relationships with former employers and colleagues.
  4. Review important aspects of a laboratory budget
  5. Discuss facets of test billing and reimbursement
  6. Review CPT coding of tests
  7. Discuss how to select which test to develop (clinical utility, target market, establishing ability to be competitive, etc.) and market the test effectively.
  8. Discuss how to decide among labs for individual tests and address market forces

 

 

Moderators:

Marco L. Leung, PhD
Assistant Clinical Director at Children's Hospital of Philadelphia

 

Joann Bodurtha, MD MPH
Professor of Genetic Medicine, Johns Hopkins Medicine

 
Presenters

https://files.abstractsonline.com/CTRL/A1/F/786/E02/1CE/47A/B80/BAB/683/CF7/483/88/a581_1.jpg

Elaine Lyon, PhD, FACMG

Director of Clinical Service Lab, HudsonAlpha Institute for Biotechnology

https://files.abstractsonline.com/CTRL/68/6/0C6/EE6/716/42E/F8C/CB2/D8C/3E0/CDF/99/a582_1.jpeg

Soma Das, PhD, FACMG

Director of Molecular Diagnostic Laboratory, Professor of Human Genetics, University of Chicago

 

https://files.abstractsonline.com/CTRL/9E/F/238/385/344/487/4A7/639/206/059/913/E3/a584_1.jpg

Peter Hulick, MD, FACMG

Director of the Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Clinical Assistant Professor, University of Chicago Pritzker School of Medicine

 

Financial Disclosures

Disclosure Statement

It is the policy of the American College of Medical Genetics and Genomics to plan and implement all of its educational activities in accordance with the ACCME Essentials and Areas and ACCME® Policies to ensure balance, independence, objectivity and scientific rigor. In accordance with the ACCME® Standards for Commercial Support, everyone (speakers, moderators, committee members and staff) who is in a position to control the content of an educational activity certified for AMA PRA Category 1 Credit™ is required to disclose all financial relationships with any commercial interests (see definition below) within the past 12 months that creates a real or apparent conflict of interest. Disclosure must include financial relationships of the individual and those of their spouse/partner. Individuals who do not disclose will be disqualified from participating in a CME activity.

This disclosure pertains to relationships with ACCME-defined commercial interests whose products or services may be related to the subject matter of the presentation topic. Any real or apparent conflicts of interest related to the content of the presentations must be managed prior to the educational activity. ACMG will identify, review and resolve all conflicts of interests prior to an educational activity being delivered to learners.

NOTE:

  • ACMG will follow the ACCME’s expectation that no employees or owners of commercial interests will be involved as planners/faculty/presenters of a CME accredited activity.
  • The ACCME definition of a commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
  • The ACCME does not consider providers of clinical service directly to patients to be commercial interests - unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.
  • Diagnostic laboratories are not considered commercial interests unless they are owned by or have a sister organization which is a commercial interest.

 

Elaine Lyon, PhD, FACMG

Dr. Lyon has disclosed that she is a consultant for Genoox.

 

Soma Das, PhD, FACMG

Has no relevant financial relationships to disclose.

 

Peter Hulick, MD, FACMG

Has no relevant financial relationships to disclose.

 

Moderator and co-moderator disclosures:

Marco L. Leung, PhD.

Has no relevant financial relationships to disclose.

 

Joann Bodurtha, MD MPH

Has no relevant financial relationships to disclose.

 

HIPAA Compliance

The ACMG supports medical information privacy.  While the ACMG is not a “covered entity” under HIPAA 1996 and therefore is not required to meet these standards, ACMG wishes to take reasonable steps to ensure that the presentation of individually identifiable health information at ACMG-sponsored events has been properly authorized.  All presenters have completed a form indicating whether they intend to present any form of individually identifiable healthcare information.  If so, they were asked either to attest that a HIPAA-compliant consent form is on file at their institution, or to send ACMG a copy of the ACMG HIPAA compliance form. This information is on record at the ACMG Administrative Office and will be made available on request.

 

Content Validation

ACMG follows the ACCME policy on Content Validation for CME activities, which requires:

 

Content Validation and Fair Balance

  1. ACMG follows the ACCME policy on Content Validation for CME activities, which requires:
  1. All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
  2. All scientific research referred to, reported or used in CME in support or justification of patient care recommendations must conform to the generally accepted standards of experimental design, data collection and analysis.

 

  1. Activities that fall outside the definition of CME/CE; “Educational activities that serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession” (source: ACCME and AMA) will not be certified for credit. CME activities that promote recommendations, treatment, or manners of practicing medicine or pharmacy that are not within the definition of CME/CE or, are known to have risks or dangers that outweigh the benefits or, are known to be ineffective in the treatment of patients.
  2. Presentations and CME/CE activity materials must give a balanced view of therapeutic options; use of generic names will contribute to this impartiality.  If the CME/CE educational materials or content includes trade names, where available, trade names from several companies must be used.

 

Off-label Uses of Products

When an off-label use of a product, or an investigational use not yet approved for any purpose, is discussed during an educational activity, the accredited sponsor shall require the speaker to disclose that the product is not labeled for the use under discussion, or that the product is still investigational. Discussions of such uses shall focus on those uses that have been subject of objective investigation.

 

Disclaimer

The ACMG does not endorse, or recommend the use of this educational program to make patient diagnoses, particular by individuals not trained in medical genetics. Adherence to the information provided in these programs does not necessarily ensure a successful diagnostic outcome. The program should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed at obtaining the same results. In determining the propriety of any specific procedure or test, a healthcare provider should apply his or her own professional judgment to the specific clinical circumstances presented by the individual patient or specimen.

 

Educational Credits are not offered

 

 

Summary
Availability: No future session
Cost: FREE
Credit Offered: No Credit Offered
Powered By